MYC and neoplasm: To identify a miRNA signature that could be used to monitor therapeutic resistance we screened 19 miRNAs with a reported role (as either regulators or effectors) in c-Myc and PIM kinase tumor activity or for their predicted regulatory role determined by TargetScan [60].